Insider · CIK 0001614740

Peetz Christopher

Reports to the SEC for 4 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001614740

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+5,305 sh	$19.19	+$102K	199,745
2026-10-06	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+6,892 sh	$15.87	+$109K	206,637
2026-10-06	MIRMMirum Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−5,305 sh	—	—	169,695
2026-10-06	MIRMMirum Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−6,892 sh	—	—	233,108
2026-09-01	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+30K sh	$2.94	+$88.1K	224,440
2026-09-01	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−8,312 sh	$98.08	−$815K	216,128
2026-09-01	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−21.7K sh	$98.91	−$2.15M	194,440
2026-09-01	MIRMMirum Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−30K sh	—	—	58,487
2026-08-10	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+20K sh	$2.94	+$58.7K	214,309
2026-08-10	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−11.7K sh	$98.51	−$1.15M	202,626
2026-08-10	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−6,017 sh	$99.25	−$597K	196,609
2026-08-10	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−2,300 sh	$100.14	−$230K	194,309
2026-08-10	MIRMMirum Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−20K sh	—	—	88,487
2026-07-15	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+4,315 sh	—	—	4,315
2026-07-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+21.5K sh	—	—	21,486
2026-07-15	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13K sh	—	—	13,010
2026-07-06	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+20K sh	$2.94	+$58.7K	214,309
2026-07-06	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−12.1K sh	$121.65	−$1.48M	202,175
2026-07-06	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−4,181 sh	$122.34	−$512K	197,994
2026-07-06	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,975 sh	$123.74	−$244K	196,019
2026-07-06	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,710 sh	$124.79	−$213K	194,309
2026-07-06	MIRMMirum Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−20K sh	—	—	108,487
2026-06-01	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+30K sh	$2.94	+$88.1K	224,309
2026-06-01	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−2,602 sh	$94.64	−$246K	221,707
2026-06-01	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−16.6K sh	$95.34	−$1.58M	205,112
2026-06-01	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−6,926 sh	$96.15	−$666K	198,186
2026-06-01	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,973 sh	$97.56	−$192K	196,213
2026-06-01	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,021 sh	$98.20	−$100K	195,192
2026-06-01	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−883 sh	$99.66	−$88K	194,309
2026-06-01	MIRMMirum Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−30K sh	—	—	128,487
2026-03-16	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−41K sh	$91.98	−$3.77M	194,309
2026-03-15	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+25K sh	—	—	185,294
2026-03-15	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+50K sh	—	—	235,294
2026-03-15	MIRMMirum Pharmaceuticals, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−25K sh	—	—	0
2026-03-15	MIRMMirum Pharmaceuticals, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−50K sh	—	—	25,000
2026-02-02	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−9,108 sh	$103.30	−$941K	160,294
2026-01-28	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+67K sh	—	—	67,000
2026-01-28	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+43.5K sh	—	—	43,500
2026-01-28	MIRMMirum Pharmaceuticals, Inc. · Performance Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+75K sh	—	—	75,000
2026-01-26	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−6,831 sh	$96.19	−$657K	169,402
2026-01-23	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+12.5K sh	—	—	176,233
2026-01-23	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−12.5K sh	—	—	12,500
2026-01-22	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−7,098 sh	$93.33	−$662K	163,733
2026-01-21	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+12.8K sh	—	—	170,831
2026-01-21	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−12.8K sh	—	—	25,593
2025-12-31	MIRMMirum Pharmaceuticals, Inc.G Gift	Director, CHIEF EXECUTIVE OFFICER	GGift	−21.1K sh	—	—	187,500
2025-11-18	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+19.1K sh	$19.24	+$368K	158,034
2025-11-18	MIRMMirum Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−19.1K sh	—	—	150,867
2025-08-11	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+40K sh	$2.94	+$117K	178,641
2025-08-11	MIRMMirum Pharmaceuticals, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−40K sh	$62.00	−$2.48M	138,641

Recent filings

Accepted (ET)
Oct 64
Peetz Christopher0001614740-26-000014
SEC(opens sec.gov)
Sep 34
Peetz Christopher0001614740-26-000013
SEC(opens sec.gov)
Aug 114
Peetz Christopher0001614740-26-000012
SEC(opens sec.gov)
Jul 174
Peetz Christopher0001628280-26-048655
SEC(opens sec.gov)
Jul 84
Peetz Christopher0001614740-26-000011
SEC(opens sec.gov)

Companies

Address

C/O MIRUM PHARMACEUTICALS, INC. 989 E HILLSDALE BLVD., SUITE 300

FOSTER CITY, CA, 94404